MDGL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $80,112,270.06

Madrigal Pharmaceuticals Insider Trading History Chart

Madrigal Pharmaceuticals Share Price & Price History

^$431.15

▲ +0.79 (0.18%)

As of 11/2/2026 04:00 PM ET

Days: 30 | 90 | 365

Madrigal Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/11/2026	William John Sibold	CEO	Sell	5,221	$542.39	$2,831,818.19	197,746
9/9/2026	William John Sibold	CEO	Sell	6,362	$535.59	$3,407,423.58	202,967
8/17/2026	Shannon T. Kelley	General Counsel	Sell	664	$514.97	$341,940.08	11,474
6/1/2026	David Soergel	Insider	Sell	1,042	$495.74	$516,561.08	10,033
5/22/2026	Richard S. Levy	Director	Sell	5,682	$515.44	$2,928,730.08	22,015
5/18/2026	David Soergel	Insider	Sell	844	$515.90	$435,419.60	11,075
3/6/2026	Carole Huntsman	Insider	Sell	419	$431.94	$180,982.86	12,692
3/6/2026	Mardi Dier	CFO	Sell	1,982	$430.87	$853,984.34	12,490
3/6/2026	Rebecca Taub	Director	Sell	491	$431.94	$212,082.54	452,213
3/6/2026	Shannon T. Kelley	General Counsel	Sell	360	$431.94	$155,498.40	12,138
3/6/2026	William John Sibold	CEO	Sell	1,663	$431.94	$718,316.22	161,829
3/2/2026	Mardi Dier	CFO	Sell	1,183	$427.21	$505,389.43	9,257
1/26/2026	Carole Huntsman	Insider	Sell	910	$493.78	$449,339.80	9,122
1/26/2026	Rebecca Taub	Director	Sell	647	$492.42	$318,595.74	452,704
1/26/2026	William John Sibold	CEO	Sell	1,577	$492.42	$776,546.34	148,497
1/20/2026	Rebecca Taub	Director	Sell	2,238	$490.77	$1,098,343.26	453,351
1/20/2026	Shannon T. Kelley	General Counsel	Sell	692	$497.36	$344,173.12	8,481
1/9/2026	Paul A. Friedman	Director	Sell	280	$551.24	$154,347.20	187,164
1/9/2026	Paul A. Friedman	Director	Sell	24,520	$522.39	$12,809,002.80	187,164
1/9/2026	Rebecca Taub	Director	Sell	240	$550.33	$132,079.20	455,589
1/9/2026	Rebecca Taub	Director	Sell	18,410	$522.40	$9,617,384.00	455,589
12/10/2025	Paul A. Friedman	Director	Sell	24,800	$552.18	$13,694,064.00	187,164
12/10/2025	Rebecca Taub	Director	Sell	18,650	$552.15	$10,297,597.50	461,044
12/4/2025	William John Sibold	CEO	Sell	2,400	$575.34	$1,380,816.00	150,074
12/2/2025	Mardi Dier	CFO	Sell	4,173	$578.34	$2,413,412.82	10,440
11/21/2025	Carole Huntsman	Insider	Sell	1,958	$553.11	$1,082,989.38	10,032
11/13/2025	Richard S. Levy	Director	Sell	8,500	$520.96	$4,428,160.00	21,197
11/5/2025	Kenneth Bate	Director	Sell	16,575	$484.30	$8,027,272.50	2,627
9/9/2025	William John Sibold	CEO	Sell	7,279	$445.63	$3,243,740.77	102,474
8/21/2025	William John Sibold	CEO	Sell	7,616	$400.18	$3,047,770.88	109,753
8/20/2025	Bros. Advisors Lp Baker	Director	Buy	59,901	$385.16	$23,071,469.16	1,947,968
8/18/2025	Bros. Advisors Lp Baker	Director	Buy	68,618	$364.04	$24,979,696.72	1,859,091
8/18/2025	Bros. Advisors Lp Baker	Director	Buy	37,164	$373.21	$13,869,976.44	1,893,120
8/18/2025	Shannon T. Kelley	General Counsel	Sell	1,304	$367.81	$479,624.24	9,173
8/15/2025	Kenneth Bate	Director	Sell	10,000	$365.20	$3,652,000.00	2,627
8/13/2025	Paul A. Friedman	Director	Sell	129,172	$370.24	$47,824,641.28	187,164
8/12/2025	Paul A. Friedman	Director	Sell	43,605	$355.68	$15,509,426.40	187,164
8/12/2025	Rebecca Taub	Director	Sell	43,263	$355.69	$15,388,216.47	461,044
8/11/2025	Paul A. Friedman	Director	Sell	3,203	$350.27	$1,121,914.81	187,164
8/11/2025	Rebecca Taub	Director	Sell	3,200	$350.24	$1,120,768.00	461,044
7/18/2025	Paul A. Friedman	Director	Sell	1,400	$350.03	$490,042.00	187,164
7/18/2025	Rebecca Taub	Director	Sell	1,000	$350.00	$350,000.00	461,044
7/17/2025	Paul A. Friedman	Director	Sell	2,700	$350.48	$946,296.00	187,164
7/17/2025	Rebecca Taub	Director	Sell	2,657	$350.41	$931,039.37	461,044
7/16/2025	Paul A. Friedman	Director	Sell	26,176	$353.47	$9,252,430.72	187,164
7/16/2025	Rebecca Taub	Director	Sell	26,444	$353.47	$9,347,160.68	461,044
3/5/2025	Robert E. Waltermire	VP	Sell	14,113	$341.32	$4,817,049.16	3,728
2/28/2025	Robert E. Waltermire	VP	Sell	1,227	$341.07	$418,492.89	3,728
2/27/2025	James M. Daly	Director	Sell	15,470	$347.45	$5,375,051.50	1,912
1/24/2025	Carole Huntsman	Insider	Sell	347	$335.24	$116,328.28	10,438
1/24/2025	Rebecca Taub	CMO	Sell	648	$335.24	$217,235.52	456,662
1/24/2025	Robert E. Waltermire	VP	Sell	103	$335.24	$34,529.72	4,955
1/24/2025	William John Sibold	CEO	Sell	1,584	$335.24	$531,020.16	54,303
1/17/2025	Rebecca Taub	CMO	Sell	1,689	$273.41	$461,789.49	457,310
1/17/2025	Robert E. Waltermire	VP	Sell	442	$273.41	$120,847.22	5,058
1/17/2025	Shannon T. Kelley	General Counsel	Sell	277	$273.41	$75,734.57	7,705
12/3/2024	Fred B. Craves	Director	Sell	3,600	$315.31	$1,135,116.00	11,000
11/25/2024	Fred B. Craves	Director	Sell	3,400	$350.30	$1,191,020.00	14,600
11/1/2024	Richard S. Levy	Director	Sell	5,000	$300.94	$1,504,700.00	11,012
9/9/2024	William John Sibold	CEO	Sell	6,363	$243.83	$1,551,490.29	55,887
6/14/2024	Robert E. Waltermire	VP	Sell	1,900	$280.00	$532,000.00	5,500
6/12/2024	Robert E. Waltermire	VP	Sell	2,000	$285.00	$570,000.00	5,500
5/21/2024	Robert E. Waltermire	VP	Sell	1,036	$231.34	$239,668.24	5,500
5/14/2024	Fred B. Craves	Director	Sell	22,489	$212.88	$4,787,458.32	413,362
4/8/2024	Paul A. Friedman	Director	Sell	26,270	$246.19	$6,467,411.30	185,735
4/8/2024	Rebecca Taub	CMO	Sell	2,676	$245.99	$658,269.24	458,999
4/5/2024	Rebecca Taub	CMO	Sell	27,506	$243.36	$6,693,860.16	458,999
4/4/2024	Paul A. Friedman	Director	Sell	18,710	$242.96	$4,545,781.60	185,735
4/3/2024	Rebecca Taub	CMO	Sell	27,845	$245.14	$6,825,923.30	458,999
4/1/2024	James M. Daly	Director	Sell	32,489	$102.77	$3,338,894.53	1,198
4/1/2024	Richard S. Levy	Director	Sell	11,000	$257.48	$2,832,280.00	10,298
12/13/2023	Bros. Advisors Lp Baker	Director	Buy	81,159	$219.39	$17,805,473.01	1,774,294
12/13/2023	Robert E. Waltermire	VP	Sell	2,500	$225.40	$563,500.00	5,667
12/4/2023	Brian Joseph Lynch	SVP	Sell	1,800	$218.87	$393,966.00	15,001
11/29/2023	Brian Joseph Lynch	SVP	Sell	4,000	$199.19	$796,760.00	15,001
11/21/2023	Bros. Advisors Lp Baker	Director	Buy	64,350	$188.47	$12,128,044.50	1,667,104
11/17/2023	Bros. Advisors Lp Baker	Director	Buy	46,370	$174.70	$8,100,839.00	1,588,541
11/14/2023	Bros. Advisors Lp Baker	Director	Buy	34,188	$156.42	$5,347,686.96	1,531,757

SEC Filings (Institutional Ownership Changes) for Madrigal Pharmaceuticals (NASDAQ:MDGL)

98.50% of Madrigal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Madrigal Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/3/2026	Allegiance Financial Group Advisory Services LLC	435	$0.22M	0.0%	N/A	0.002%
11/3/2026	Calamos Advisors LLC	3,009	$1.52M	0.0%	+83.3%	0.013%
11/2/2026	Kestra Advisory Services LLC	1,297	$0.65M	0.0%	-3.9%	0.006%
11/2/2026	Commonwealth Equity Services LLC	1,664	$0.84M	0.0%	+2.7%	0.007%
10/31/2026	Chicago Partners Investment Group LLC	1,538	$0.67M	0.0%	+56.8%	0.007%
10/30/2026	Provenance Wealth Advisors LLC	136	$69K	0.0%	N/A	0.001%
10/29/2026	Mirae Asset Global Investments Co. Ltd.	31,624	$15.94M	0.0%	N/A	0.137%
10/29/2026	Profund Advisors LLC	3,960	$2M	0.1%	+38.9%	0.017%
10/29/2026	ProShare Advisors LLC	838	$0.42M	0.0%	+5.5%	0.004%
10/29/2026	Vise Technologies Inc.	1,348	$0.68M	0.0%	+61.6%	0.006%
10/29/2026	Americana Partners LLC	418	$0.21M	0.0%	N/A	0.002%
10/29/2026	State of Wyoming	1,575	$0.79M	0.1%	-34.6%	0.007%
10/28/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	2,040	$1.03M	0.0%	+13.3%	0.009%
10/28/2026	Parcion Private Wealth LLC	697	$0.35M	0.0%	N/A	0.003%
10/28/2026	China Universal Asset Management Co. Ltd.	4,216	$2.15M	0.1%	+14.9%	0.000%
10/26/2026	Oppenheimer & Co. Inc.	540	$0.27M	0.0%	+9.8%	0.002%
10/26/2026	Park Avenue Securities LLC	603	$0.30M	0.0%	-5.6%	0.003%
10/24/2026	EULAV Asset Management	51,000	$25.70M	0.9%	-1.9%	0.221%
10/23/2026	Citizens Financial Group Inc. RI	1,730	$0.87M	0.0%	N/A	0.007%
10/23/2026	Sterling Capital Management LLC	264	$0.13M	0.0%	-8.7%	0.001%
10/23/2026	Inspire Investing LLC	1,220	$0.62M	0.0%	+7.0%	0.005%
10/22/2026	MBL Wealth LLC	1,045	$0.53M	0.0%	N/A	0.005%
10/22/2026	Root Financial Partners LLC	162	$82K	0.0%	N/A	0.001%
10/21/2026	Crossmark Global Holdings Inc.	643	$0.32M	0.0%	+35.4%	0.003%
10/21/2026	Nisa Investment Advisors LLC	160	$81K	0.0%	-53.9%	0.001%
10/19/2026	Abel Hall LLC	1,286	$0.65M	0.1%	-7.4%	0.006%
10/17/2026	IFP Advisors Inc	779	$0.39M	0.0%	+65.0%	0.003%
10/16/2026	NFSG Corp	2,998	$1.51M	0.2%	-2.1%	0.013%
10/15/2026	Assenagon Asset Management S.A.	20,741	$10.45M	0.0%	-83.3%	0.090%
10/15/2026	Curated Wealth Partners LLC	398	$0.20M	0.0%	N/A	0.002%
10/14/2026	Krilogy Financial LLC	1,004	$0.47M	0.0%	N/A	0.004%
10/13/2026	Sivik Global Healthcare LLC	2,500	$1.26M	0.8%	N/A	0.011%
10/13/2026	NorthCrest Asset Manangement LLC	888	$0.42M	0.0%	N/A	0.004%
10/9/2026	GAMMA Investing LLC	279	$0.14M	0.0%	+62.2%	0.001%
10/8/2026	Farther Finance Advisors LLC	862	$0.43M	0.0%	+713.2%	0.004%
9/9/2026	Tidal Investments LLC	1,631	$0.88M	0.0%	+5.2%	0.007%
9/9/2026	Engineers Gate Manager LP	1,320	$0.71M	0.0%	N/A	0.006%
9/8/2026	Arizona State Retirement System	4,114	$2.21M	0.0%	+1.5%	0.018%
9/8/2026	Nykredit A S	663	$0.36M	0.0%	N/A	0.003%
8/27/2026	Corient Private Wealth LP	1,446	$0.78M	0.0%	-2.0%	0.006%
8/26/2026	Amundi	1,386	$0.74M	0.0%	+13.2%	0.006%
8/26/2026	HighTower Advisors LLC	12,063	$6.48M	0.0%	-13.3%	0.052%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	1,800	$0.97M	0.0%	N/A	0.008%
8/22/2026	Seven Fleet Capital Management LP	4,973	$2.67M	0.4%	+46.6%	0.022%
8/22/2026	Concurrent Investment Advisors LLC	1,034	$0.56M	0.0%	+2.0%	0.004%
8/21/2026	AXQ Capital LP	929	$0.50M	0.1%	N/A	0.004%
8/21/2026	Nykredit A S	663	$0.36M	0.0%	N/A	0.003%
8/20/2026	Two Sigma Securities LLC	2,219	$1.19M	0.1%	N/A	0.010%
8/20/2026	GTS Securities LLC	392	$0.21M	0.0%	N/A	0.002%
8/20/2026	Penn Capital Management Company LLC	2,811	$1.53M	0.1%	-19.9%	0.012%
8/20/2026	Greenwood Capital Associates LLC	773	$0.42M	0.0%	+13.3%	0.003%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	32,403	$17.40M	0.0%	+36.2%	0.140%
8/19/2026	Hsbc Holdings PLC	20,240	$10.87M	0.0%	+1,738.3%	0.088%
8/19/2026	Wellington Management Group LLP	825,714	$443.37M	0.1%	+18.8%	3.575%
8/18/2026	Beacon Pointe Advisors LLC	966	$0.52M	0.0%	N/A	0.004%
8/18/2026	Palo Alto Investors LP	1,787	$0.96M	0.0%	N/A	0.008%
8/18/2026	Centaurus Financial Inc.	721	$0.39M	0.0%	N/A	0.003%
8/18/2026	Jefferies Financial Group Inc.	633	$0.34M	0.0%	N/A	0.003%
8/18/2026	Public Employees Retirement System of Ohio	5,105	$2.74M	0.0%	N/A	0.022%
8/17/2026	Seven Fleet Capital Management LP	4,973	$2.67M	0.0%	N/A	0.022%
8/17/2026	Corient Private Wealth LP	1,512	$0.81M	0.0%	N/A	0.007%
8/17/2026	Bamco Inc. NY	4,500	$2.42M	0.0%	N/A	0.019%
8/17/2026	Bank of America Corp DE	134,036	$71.97M	0.0%	N/A	0.580%
8/15/2026	Freestone Grove Partners LP	1,552	$0.83M	0.0%	N/A	0.007%
8/15/2026	Paulson & CO. Inc.	1,340,020	$719.52M	27.9%	N/A	5.801%
8/15/2026	Jupiter Topco LLC	1,936,099	$1.04B	0.4%	N/A	8.381%
8/15/2026	J. Goldman & Co LP	5,069	$2.72M	0.1%	N/A	0.022%
8/14/2026	ADAR1 Capital Management LLC	895	$0.48M	0.0%	N/A	0.004%
8/14/2026	Hsbc Holdings PLC	20,240	$10.87M	0.0%	N/A	0.088%
8/14/2026	EFG International AG	9,980	$5.36M	0.1%	N/A	0.043%
8/14/2026	Canada Pension Plan Investment Board	29,080	$15.62M	0.0%	N/A	0.126%
8/14/2026	Castleark Management LLC	5,076	$2.73M	0.1%	N/A	0.022%
8/14/2026	Legal & General Group Plc	12,348	$6.63M	0.0%	N/A	0.053%
8/14/2026	The Manufacturers Life Insurance Company	12,196	$6.55M	0.0%	N/A	0.053%
8/14/2026	Nan Fung Group Holdings Ltd	5,672	$3.05M	0.0%	N/A	0.025%
8/14/2026	Algert Global LLC	3,200	$1.72M	0.0%	-60.8%	0.014%
8/13/2026	Sanctuary Advisors LLC	1,120	$0.60M	0.0%	N/A	0.005%
8/13/2026	Connor Clark & Lunn Investment Management Ltd.	1,782	$0.96M	0.0%	N/A	0.008%
8/12/2026	Elevation Point Wealth Partners LLC	438	$0.24M	0.0%	N/A	0.002%
8/12/2026	Quantbot Technologies LP	253	$0.14M	0.0%	N/A	0.001%
8/12/2026	William Blair Investment Management LLC	324,123	$174.04M	0.5%	N/A	1.403%
8/12/2026	EP Wealth Advisors LLC	646	$0.35M	0.0%	N/A	0.003%
8/11/2026	Allworth Financial LP	3,562	$1.91M	0.0%	N/A	0.015%
8/11/2026	B. Metzler seel. Sohn & Co. AG	1,221	$0.66M	0.0%	N/A	0.005%
8/11/2026	Vise Technologies Inc.	834	$0.45M	0.0%	N/A	0.004%
8/11/2026	E Fund Management Co. Ltd.	873	$0.47M	0.0%	N/A	0.004%
8/7/2026	BlackRock Inc.	1,200,770	$644.75M	0.0%	N/A	5.198%
8/7/2026	Deutsche Bank AG	83,916	$45.06M	0.0%	N/A	0.363%
8/7/2026	Persistent Asset Partners Ltd	54	$29K	0.0%	N/A	0.000%
8/7/2026	OneDigital Investment Advisors LLC	461	$0.25M	0.0%	N/A	0.002%
8/6/2026	Global Retirement Partners LLC	63	$34K	0.0%	N/A	0.000%
8/6/2026	Bank of New York Mellon Corp	128,520	$69.01M	0.0%	N/A	0.556%
8/6/2026	State of Wyoming	2,410	$1.29M	0.1%	N/A	0.010%
8/6/2026	GSA Capital Partners LLP	789	$0.42M	0.0%	N/A	0.003%
8/3/2026	Oppenheimer Asset Management Inc.	1,236	$0.66M	0.0%	N/A	0.005%
7/10/2026	Tema ETFs LLC	1,499	$0.81M	0.0%	-3.4%	0.007%
7/10/2026	Handelsbanken Fonder AB	5,680	$3.05M	0.0%	+6.0%	0.025%
7/9/2026	Hennion & Walsh Asset Management Inc.	8,684	$4.66M	0.1%	+0.8%	0.038%
7/8/2026	Assenagon Asset Management S.A.	124,214	$66.70M	0.1%	+674.7%	0.539%
7/7/2026	GAMMA Investing LLC	172	$92K	0.0%	+35.4%	0.001%

Data available starting January 2016

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.

Today's Range

Now: $431.15

$425.33

$436.74

50 Day Range

MA: $496.95

$430.36

$546.93

52 Week Range

Now: $431.15

$399.00

$615.00

Volume

495,068 shs

Average Volume

299,882 shs

Market Capitalization

$9.96 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top insider investors include:
Bruce Kovner (Director)
Safi Bahcall (CEO)
Bros Advisors Lp Baker (Director)
Rebecca Taub (Director)
Rebecca Taub (CMO)
Fred B Craves (Director)
Keith R Gollust (Director)
Bay City Capital Llc (Major Shareholder)
William John Sibold (CEO)
Paul A Friedman (Director)
Learn More about top insider investors at Madrigal Pharmaceuticals.
Who are the major institutional investors of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top institutional shareholders include:
EULAV Asset Management — 0.22%
Mirae Asset Global Investments Co. Ltd. — 0.14%
Assenagon Asset Management S.A. — 0.09%
China Universal Asset Management Co. Ltd. — 0.00%
Profund Advisors LLC — 0.02%
NFSG Corp — 0.01%
Learn More about top institutional investors of Madrigal Pharmaceuticals stock.
Which major investors are selling Madrigal Pharmaceuticals stock?: During the last quarter, MDGL stock was sold by these institutional investors:
Assenagon Asset Management S.A.
EULAV Asset Management
State of Wyoming
Nisa Investment Advisors LLC
Abel Hall LLC
NFSG Corp
Kestra Advisory Services LLC
Park Avenue Securities LLC
Within the previous year, company insiders that have sold Madrigal Pharmaceuticals company stock include:
Rebecca Taub (Director)
William John Sibold (CEO)
Paul A Friedman (Director)
Richard S Levy (Director)
Carole Huntsman (Insider)
Mardi Dier (CFO)
Shannon T Kelley (General Counsel)
David Soergel (Insider)
Kenneth Bate (Director)
Learn More investors selling Madrigal Pharmaceuticals stock.
Which major investors are buying Madrigal Pharmaceuticals stock?: Within the last quarter, MDGL stock was purchased by institutional investors including:
Mirae Asset Global Investments Co. Ltd.
Sivik Global Healthcare LLC
Citizens Financial Group Inc. RI
Profund Advisors LLC
MBL Wealth LLC
Krilogy Financial LLC
NorthCrest Asset Manangement LLC
Farther Finance Advisors LLC